Glucose-Mediated N-glycosylation of SCAP Is Essential for SREBP-1 Activation and Tumor Growth
Chunming Cheng(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Deliang Guo(Wuhan University), Ji Young Yoo(The University of Texas MD Anderson Cancer Center), Jianjie Ma(National Yang Ming Chiao Tung University), Arnab Chakravarti(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Balveen Kaur(Augusta University), Peng Hu(The Ohio State University), Étienne Lefai(Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement), Axel Nohturfft(Harvard University), Vanessa Euthine(Lyon 1 Université), Feng Geng(The Ohio State University), Xiaoning Wu(The Ohio State University), Jeffrey Yunhua Guo(The Ohio State University), Xiang Cheng(Union Hospital), Peng Ru(The Ohio State University), Junfeng Liu(Sichuan Cancer Hospital)
Cited by 336
Related Papers
Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses
|Proceedings of the National Academy of Sciences|2006|360
Inhibition of SOAT1 Suppresses Glioblastoma Growth via Blocking SREBP-1–Mediated Lipogenesis
|Clinical Cancer Research|2016|332
The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis
|Proceedings of the National Academy of Sciences|2009|235
VEGF-specific Short Hairpin RNA–expressing Oncolytic Adenovirus Elicits Potent Inhibition of Angiogenesis and Tumor Growth
|Molecular Therapy|2007|150
RNA Nanoparticle-Based Targeted Therapy for Glioblastoma through Inhibition of Oncogenic miR-21
|Molecular Therapy|2017|147